Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of SI-613 in Osteoarthritis of Shoulder, Elbow, Hip and Ankle
jRCT2080223622Phase 3Completed
- Sponsor
- Seikagaku Corporation
- Start
- Aug 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) and Osteoarthritis of the elbow comparing SI-613 with Placebo (2 arms). Started Aug 2017; status: completed.
02
Drugs
diclofenac etalhyaluronate
03
Conditions
osteoarthritis (OA)Osteoarthritis of the elbow
Beyond the preview
Go deeper on jRCT2080223622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223622.